Literature DB >> 21705327

Thioredoxin regulates adipogenesis through thioredoxin-interacting protein (Txnip) protein stability.

William A Chutkow1, Richard T Lee.   

Abstract

Txnip (thioredoxin-interacting protein) is a critical mediator of metabolism and adipogenesis in vivo. The mechanisms of action of Txnip are believed to operate at least in part by inhibiting the redox signaling functions of thioredoxin. We tested here whether Txnip suppressed adipogenesis by inhibiting thioredoxin and discovered a reversal of roles; Txnip inhibits adipogenesis directly, and thioredoxin binding regulates Txnip by enhancing Txnip protein stability. Unlike Txnip, a Txnip mutant that cannot bind thioredoxin (C247S) did not prevent adipocyte differentiation, but was degraded more quickly by proteasomal targeting. Finding that endogenous Txnip protein is also rapidly degraded at the onset of adipogenesis suggested that Txnip degradation is required for adipocyte differentiation. Thioredoxin overexpression stabilized Txnip protein levels to inhibit adipogenesis, and adipogenic stimulants such as insulin promoted Txnip-thioredoxin dissociation to the more labile free Txnip state. As an α-arrestin protein, Txnip has two C-terminal tail PPXY motifs that mediate E3 ubiquitin ligase binding and Txnip protein stability. Mutating the PPXY motifs prevented Txnip degradation, even when thioredoxin binding was lost, and restored the ability of C247S Txnip to inhibit adipogenesis. These studies present a novel reconsideration of Txnip-thioredoxin signaling by showing that thioredoxin regulates the intrinsic function of Txnip as an inhibitor of adipogenesis through protein stabilization.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21705327      PMCID: PMC3190721          DOI: 10.1074/jbc.M111.267666

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Thioredoxin and related molecules--from biology to health and disease.

Authors:  Christopher Horst Lillig; Arne Holmgren
Journal:  Antioxid Redox Signal       Date:  2007-01       Impact factor: 8.401

Review 2.  The structural basis of arrestin-mediated regulation of G-protein-coupled receptors.

Authors:  Vsevolod V Gurevich; Eugenia V Gurevich
Journal:  Pharmacol Ther       Date:  2006-02-03       Impact factor: 12.310

Review 3.  Endocytic adaptors--social networking at the plasma membrane.

Authors:  Amanda Reider; Beverly Wendland
Journal:  J Cell Sci       Date:  2011-05-15       Impact factor: 5.285

4.  The interaction of thioredoxin with Txnip. Evidence for formation of a mixed disulfide by disulfide exchange.

Authors:  Parth Patwari; Luke J Higgins; William A Chutkow; Jun Yoshioka; Richard T Lee
Journal:  J Biol Chem       Date:  2006-06-09       Impact factor: 5.157

5.  Vitamin D3 up-regulated protein 1 mediates oxidative stress via suppressing the thioredoxin function.

Authors:  E Junn; S H Han; J Y Im; Y Yang; E W Cho; H D Um; D K Kim; K W Lee; P L Han; S G Rhee; I Choi
Journal:  J Immunol       Date:  2000-06-15       Impact factor: 5.422

6.  A possible interaction of thioredoxin with VDUP1 in HeLa cells detected in a yeast two-hybrid system.

Authors:  H Yamanaka; F Maehira; M Oshiro; T Asato; Y Yanagawa; H Takei; Y Nakashima
Journal:  Biochem Biophys Res Commun       Date:  2000-05-19       Impact factor: 3.575

7.  Thioredoxin-interacting protein deficiency disrupts the fasting-feeding metabolic transition.

Authors:  Sonal S Sheth; Lawrence W Castellani; Soumya Chari; Cory Wagg; Christopher K Thipphavong; Jackie S Bodnar; Peter Tontonoz; Alan D Attie; Gary D Lopaschuk; Aldons J Lusis
Journal:  J Lipid Res       Date:  2004-11-01       Impact factor: 5.922

8.  Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression.

Authors:  A Nishiyama; M Matsui; S Iwata; K Hirota; H Masutani; H Nakamura; Y Takagi; H Sono; Y Gon; J Yodoi
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

9.  Association of anti-obesity activity of N-acetylcysteine with metallothionein-II down-regulation.

Authors:  Jae Ryong Kim; Hyung Ho Ryu; Hyun Jin Chung; Joo Hyun Lee; Sang Woon Kim; Woo Hyung Kwun; Suk Hwan Baek; Jung Hye Kim
Journal:  Exp Mol Med       Date:  2006-04-30       Impact factor: 8.718

10.  Mice lacking thioredoxin-interacting protein provide evidence linking cellular redox state to appropriate response to nutritional signals.

Authors:  To Yuen Hui; Sonal S Sheth; J Matthew Diffley; Douglas W Potter; Aldons J Lusis; Alan D Attie; Roger A Davis
Journal:  J Biol Chem       Date:  2004-03-26       Impact factor: 5.157

View more
  28 in total

1.  Resveratrol Decreases TXNIP mRNA and Protein Nuclear Expressions With an Arterial Function Improvement in Old Mice.

Authors:  Tatiana Bedarida; Stephanie Baron; Françoise Vibert; Audrey Ayer; Daniel Henrion; Elizabeth Thioulouse; Carmen Marchiol; Jean-Louis Beaudeux; Charles-Henry Cottart; Valerie Nivet-Antoine
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2015-06-03       Impact factor: 6.053

Review 2.  'Metabolically healthy obesity': origins and implications.

Authors:  Gerald V Denis; Martin S Obin
Journal:  Mol Aspects Med       Date:  2012-10-13

3.  TXNIP in Agrp neurons regulates adiposity, energy expenditure, and central leptin sensitivity.

Authors:  Clemence Blouet; Shun-Mei Liu; Young-Hwan Jo; Streamson Chua; Gary J Schwartz
Journal:  J Neurosci       Date:  2012-07-18       Impact factor: 6.167

4.  The relationship of thioredoxin-1 and cisplatin resistance: its impact on ROS and oxidative metabolism in lung cancer cells.

Authors:  Medhi Wangpaichitr; Elizabeth J Sullivan; George Theodoropoulos; Chunjing Wu; Min You; Lynn G Feun; Theodore J Lampidis; Macus T Kuo; Niramol Savaraj
Journal:  Mol Cancer Ther       Date:  2012-01-16       Impact factor: 6.261

5.  Redox redux: protecting the ischemic myocardium.

Authors:  Oded N Spindel; Bradford C Berk
Journal:  J Clin Invest       Date:  2011-12-27       Impact factor: 14.808

Review 6.  Thioredoxin and thioredoxin target proteins: from molecular mechanisms to functional significance.

Authors:  Samuel Lee; Soo Min Kim; Richard T Lee
Journal:  Antioxid Redox Signal       Date:  2012-06-26       Impact factor: 8.401

Review 7.  Thioredoxin interacting protein: redox dependent and independent regulatory mechanisms.

Authors:  Oded N Spindel; Cameron World; Bradford C Berk
Journal:  Antioxid Redox Signal       Date:  2011-12-20       Impact factor: 8.401

Review 8.  The role of the thioredoxin/thioredoxin reductase system in the metabolic syndrome: towards a possible prognostic marker?

Authors:  Alexey A Tinkov; Geir Bjørklund; Anatoly V Skalny; Arne Holmgren; Margarita G Skalnaya; Salvatore Chirumbolo; Jan Aaseth
Journal:  Cell Mol Life Sci       Date:  2018-01-11       Impact factor: 9.261

9.  A Txnrd1-dependent metabolic switch alters hepatic lipogenesis, glycogen storage, and detoxification.

Authors:  Sonya V Iverson; Sofi Eriksson; Jianqiang Xu; Justin R Prigge; Emily A Talago; Tesia A Meade; Erin S Meade; Mario R Capecchi; Elias S J Arnér; Edward E Schmidt
Journal:  Free Radic Biol Med       Date:  2013-06-03       Impact factor: 7.376

10.  Acupuncture inhibits TXNIP-associated oxidative stress and inflammation to attenuate cognitive impairment in vascular dementia rats.

Authors:  Si-Qi Du; Xue-Rui Wang; Wen Zhu; Yang Ye; Jing-Wen Yang; Si-Ming Ma; Cai-Shuo Ji; Cun-Zhi Liu
Journal:  CNS Neurosci Ther       Date:  2017-11-06       Impact factor: 5.243

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.